Bristol Myers Squibb has announced positive topline results from its phase 3 trial of Reblozyl (luspatercept-aamt), the first erythroid maturation agent for first-line treatment of patients with ...

Approval in previously untreated, lower-risk MDS patients who may need red blood cell transfusions represents a big step up in the eligible patient population for the drug and has been viewed as ...

Myelodysplastic syndrome articles from across Nature Portfolio The myelodysplastic syndromes (MDS) are disorders of the haematopoietic stem cells in the bone marrow, that result in a decreased ...

Motorimagery EEG classification plays a crucial role in non-invasive Brain-Computer Interface (BCI) research. However, the performance of classification is affected by the non-stationarity and ...

Advanced Charting Compare Compare to Benchmark: DJIA S&P 500 GLOBAL DOW NASDAQ Financial Services Compare to Open 16.60 Prior Close 16.50 (06/30/25) 1 Day FAB 0.61% DJIA 0.63% S&P 500 0.52% ...